Latest News & Features
Africa
More than 150 tonnes of counterfeit medicine have been seized in southern Africa. 22 September 2015
Americas
Acorda Therapeutics has sued rival Par Pharmaceutical accusing it of infringing patents related to multiple sclerosis treatment drug Ampyra. 21 September 2015
Americas
Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid. 18 September 2015
Americas
The US Food and Drug Administration has introduced a rule enabling it to destroy certain drugs that have been refused entry into the US. 17 September 2015
Asia
The Indian Pharmaceutical Alliance has dropped its opposition to a patent application filed by Gilead Sciences covering its hepatitis C drug Sovaldi. 16 September 2015
Americas
A US appeals court has revived a dispute in which a lower court previously ruled that there should not be a trial to determine whether pharmaceutical company Hospira infringed three patents. 14 September 2015
Big Pharma
The English High Court has ruled that Pfizer’s second medical use patent covering its drug Lyrica (pregabalin) is invalid and that the pharmaceutical company is liable for making “groundless threats” of infringement. 11 September 2015
Biotechnology
Supplementary protection certificates should take effect once an applicant for marketing authorisation has been notified of the authorisation, an advocate-general has urged the Court of Justice of the European Union to confirm. 10 September 2015
Biotechnology
An adviser at Europe’s highest court is expected to issue an opinion on whether the term of a supplementary protection certificate begins once it is authorised or when the applicant has been notified about it. 9 September 2015
Asia
Pfizer has had a patent application for tofacitinib, which is marketed as Xeljanz and Jakvinus, rejected by the Indian Patent Office for the second time. 8 September 2015